Free Trial

IperionX (NASDAQ:IPX) Stock Price Down 5% - Here's What Happened

IperionX logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • IperionX shares fell 5% to approximately $14.84, with trading volume down 79% from the stock’s average daily volume.
  • Analyst sentiment remains largely positive: six analysts rate the stock a Buy versus one Sell, producing a consensus rating of “Moderate Buy” and an average price target of $42.00.
  • The company reported a quarterly loss of $0.50 per share, while institutional investors have recently increased or initiated positions; funds and hedge funds collectively own 2.76% of IPX.
  • MarketBeat previews top five stocks to own in November.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) fell 5% during trading on Tuesday. The company traded as low as $14.75 and last traded at $14.8350. 56,558 shares traded hands during trading, a decline of 79% from the average daily volume of 274,000 shares. The stock had previously closed at $15.62.

Analyst Upgrades and Downgrades

IPX has been the subject of several research analyst reports. Weiss Ratings reiterated a "sell (e+)" rating on shares of IperionX in a research report on Friday, July 17th. B. Riley Financial lowered their target price on IperionX from $52.00 to $34.00 and set a "buy" rating for the company in a research note on Wednesday, September 30th. Jefferies Financial Group began coverage on IperionX in a research note on Wednesday, September 2nd. They issued a "buy" rating and a $26.00 target price for the company. Finally, Roth Capital set a $53.00 price target on IperionX in a report on Wednesday, August 5th. Six research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $42.00.

Check Out Our Latest Analysis on IPX

IperionX Trading Down 5.1%

The firm has a 50 day moving average price of $20.66 and a 200-day moving average price of $27.27. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.95 and a current ratio of 3.24.

IperionX (NASDAQ:IPX - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported ($0.50) earnings per share for the quarter. Research analysts anticipate that IperionX Limited Sponsored ADR will post -0.13 EPS for the current fiscal year.

Institutional Investors Weigh In On IperionX

Several institutional investors have recently modified their holdings of IPX. GAMMA Investing LLC lifted its holdings in IperionX by 40.3% in the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock valued at $50,000 after buying an additional 483 shares during the period. Connective Capital Management LLC bought a new position in IperionX in the second quarter valued at approximately $160,000. DLD Asset Management LP acquired a new stake in IperionX during the 1st quarter worth $260,000. Corigliano Investment Advisers LLC acquired a new stake in IperionX during the 4th quarter worth $362,000. Finally, Private Advisor Group LLC raised its position in shares of IperionX by 69.9% during the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock valued at $1,643,000 after acquiring an additional 25,964 shares during the last quarter. Institutional investors and hedge funds own 2.76% of the company's stock.

IperionX Company Profile

(Get Free Report)

IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines